{"id":24032,"date":"2013-12-01T11:50:03","date_gmt":"2013-12-01T11:50:03","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=24032"},"modified":"2016-11-04T15:49:19","modified_gmt":"2016-11-04T15:49:19","slug":"14th-european-aids-conference-eacs-16-19-october-2013-brussels","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/24032","title":{"rendered":"14th European AIDS Conference (EACS), 16-19 October 2013, Brussels"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-24101\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2013\/12\/EACS-2013-logo-300x226.png\" alt=\"EACS 2013 logo\" width=\"210\" height=\"158\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2013\/12\/EACS-2013-logo-300x226.png 300w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2013\/12\/EACS-2013-logo.png 349w\" sizes=\"auto, (max-width: 210px) 100vw, 210px\" \/>The 14th European AIDS Conference (EACS) was held from 16-19 October 2013 in Brussels.<\/strong><\/p>\n<p>This marked the 25th anniversary of the European Clinical AIDS Society which organises these biennial meetings.<\/p>\n<p>Access to the programme and abstracts this year uses a new web interface, which helpfully already includes access to PDF files for many of the posters.<\/p>\n<p><a href=\"http:\/\/www.eacsmobile.org\/\">http:\/\/www.eacsmobile.org\/<\/a><\/p>\n<p>Abstracts:<br \/>\n<a href=\"http:\/\/www.abstractserver.com\/eacsabstractarchive\">http:\/\/www.abstractserver.com\/eacsabstractarchive<\/a><\/p>\n<p>E posters:<br \/>\n<a href=\"http:\/\/www.abstractstosubmit.com\/eacs2013\/eposter\">http:\/\/www.abstractstosubmit.com\/eacs2013\/eposter<\/a><\/p>\n<p>Webcasts (free registration required):<br \/>\n<a href=\"http:\/\/www.multiwebcast.com\/eacs\/2013\/14th\/listing\">http:\/\/www.multiwebcast.com\/eacs\/2013\/14th\/listing<\/a><\/p>\n<p>Articles in this issue include:<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/24030\">Dolutegravir superior to darunavir\/r at week 48 in open label treatment na\u00efve study<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24027\">GSK744: 24-week results with oral integrase inhibitor planned for once-monthly injections<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24025\">Cenicriviroc: 48 week results compared to efavirenz<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24023\">Approaches to once-daily raltegravir: new formulation likely to require food<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24021\">DSMB stops boosted atazanavir monotherapy study due to virological failure<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24019\">Recreational drug use is common in HIV positive gay men and is extensive in a significant minority<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24017\">Caution against prolonged use of bisphosphonates in patients with mild-moderate fracture risk<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24015\">Osteoporosis triples risk of later fracture in 1000-person US HIV group<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24013\">Bone turnover marker changes early in ART predict bone loss after 96 week<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24011\">Low HDL cholesterol Is main lipid abnormality in HIV+\/HIV- comparison<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/24009\">Classic risk factors, but not HIV, linked to arterial stiffness in middle-aged<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>More then ten reports from EACS 2013, including new ARVs, recreational drug use by gay men, side effects and bone health&#8230;<\/p>\n","protected":false},"author":2,"featured_media":24067,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,181],"class_list":["post-24032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-conference-reports","tag-conference-index","tag-eacs-14-brussels-2013"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/24032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=24032"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/24032\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media\/24067"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=24032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=24032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=24032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}